We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAKE icon
1201
Cheesecake Factory
CAKE
$4.42B
$223K ﹤0.01%
+5,502
New +$209K
CPT icon
1202
Camden Property Trust
CPT
$11.4B
$223K ﹤0.01%
+1,805
New +$213K
SMCI icon
1203
Super Micro Computer
SMCI
$18.4B
$223K ﹤0.01%
5,350
+1,240
+30% +$75.5K
ETSY icon
1204
Etsy
ETSY
$8.21B
$222K ﹤0.01%
+4,004
New +$227K
CWI icon
1205
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.73B
$218K ﹤0.01%
7,175
– –
AGYS icon
1206
Agilysys
AGYS
$3.12B
$217K ﹤0.01%
+1,994
New +$213K
LEG icon
1207
Leggett & Platt
LEG
$1.47B
$217K ﹤0.01%
15,949
+4,074
+34% +$50.9K
NVST icon
1208
Envista
NVST
$4.39B
$217K ﹤0.01%
+10,965
New +$191K
NOBL icon
1209
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$217K ﹤0.01%
+4,056
New +$206K
BUD icon
1210
AB InBev
BUD
$161B
$216K ﹤0.01%
+3,258
New +$201K
DEA
1211
Easterly Government Properties
DEA
$1.17B
$215K ﹤0.01%
6,343
+1,437
+29% +$48.1K
PNFP icon
1212
Pinnacle Financial Partners Inc
PNFP
$15.9B
$215K ﹤0.01%
+2,195
New +$202K
FIX icon
1213
Comfort Systems
FIX
$57.2B
$214K ﹤0.01%
+549
New +$181K
TTD icon
1214
Trade Desk
TTD
$8.89B
$213K ﹤0.01%
1,942
-159
-8% -$15.9K
STLA icon
1215
Stellantis
STLA
$16.7B
$213K ﹤0.01%
15,130
-1,990
-12% -$33.8K
OSW icon
1216
OneSpaWorld
OSW
$2.82B
$210K ﹤0.01%
+12,715
New +$201K
NICE icon
1217
Nice
NICE
$5.94B
$209K ﹤0.01%
+1,201
New +$206K
UMC icon
1218
United Microelectronic
UMC
$43.6B
$208K ﹤0.01%
24,696
+4,696
+23% +$39.3K
RDY icon
1219
Dr. Reddy's Laboratories
RDY
$9.77B
$207K ﹤0.01%
+13,055
New +$210K
BKE icon
1220
Buckle
BKE
$2.35B
$207K ﹤0.01%
+4,704
New +$193K
EXI icon
1221
iShares Global Industrials ETF
EXI
$1.41B
$207K ﹤0.01%
1,390
– –
SPB icon
1222
Spectrum Brands
SPB
$2.08B
$207K ﹤0.01%
+2,172
New +$192K
TW icon
1223
Tradeweb Markets
TW
$22.2B
$206K ﹤0.01%
+1,665
New +$189K
BOTZ icon
1224
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.17B
$206K ﹤0.01%
6,392
+1,589
+33% +$48.7K
SLAB icon
1225
Silicon Laboratories
SLAB
$7.17B
$205K ﹤0.01%
+1,772
New +$198K
47 48
49
50 51

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.